Cingulate Inc. Short Interest Down 86.9 percent in November

CING Stock  USD 4.36  0.16  3.81%   
Roughly 56% of all Cingulate's stockholders are looking to take a long position. The analysis of the overall investor sentiment regarding Cingulate suggests that some traders are interested. The current market sentiment, together with Cingulate's historical and current headlines, can help investors time the market. In addition, many technical investors use Cingulate stock news signals to limit their universe of possible portfolio assets.
  
Cingulate Inc. saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 10,600 shares, a decline of 86.9 percent from the November 15th total of 80,800 shares. Approximately 0.1 percent of the shares of the company are short sold. Based on

Read at thelincolnianonline.com
news
  

Cingulate Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cingulate can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cingulate Fundamental Analysis

We analyze Cingulate's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cingulate using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cingulate based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Cingulate is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Cingulate Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cingulate stock to make a market-neutral strategy. Peer analysis of Cingulate could also be used in its relative valuation, which is a method of valuing Cingulate by comparing valuation metrics with similar companies.

Peers

Cingulate Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
MNPRMonopar Therapeutics   8.84   
0%
40.0%
GNLXGenelux Common   8.03   
0%
36.0%
IKTInhibikase Therapeutics   6.96   
0%
31.0%
ADAGAdagene   1.30   
0%
5.0%
PMVPPmv Pharmaceuticals   1.25   
0%
5.0%
RZLTRezolute   1.00   
0%
4.0%
SNTISenti Biosciences   0.93   
0%
4.0%
ACRVAcrivon Therapeutics,   0.80   
0%
3.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
AVTEAerovate Therapeutics   0.38   
1.0%
0%
DYAIDyadic International   8.56   
39.0%
0%

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account